Outlook Therapeutics Inc. (NASDAQ: OTLK) Stock Information | RedChip

Outlook Therapeutics Inc. (NASDAQ: OTLK) Listen to this Section


$7.69
+0.0100 ( +0.13% ) 197.7K

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Market Data


Open


$7.69

Previous close


$7.68

Volume


197.7K

Market cap


$180.46M

Day range


$7.48 - $8.06

52 week range


$4.00 - $29.20

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Mar 07, 2024
10-q Quarterly Reports 70 Feb 14, 2024
8-k 8K-related 16 Feb 14, 2024
ars Annual reports 1 Feb 08, 2024
def Proxies and info statements 6 Feb 08, 2024
pre Proxies and info statements 6 Jan 29, 2024
8-k 8K-related 22 Jan 24, 2024
10-k/a Quarterly Reports 14 Jan 24, 2024
8-k 8K-related 13 Dec 22, 2023
10-k Annual reports 85 Dec 22, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.